In the study, half the participants lost 15% of their body weight while on a compounded GLP-1
Carnitine also has osmoprotective properties, which can inhibit the activation of transient receptor potential vanilloid type 1 (TRPV1) and protect corneal and conjunctival cells from hyperosmotic stress in dry eye [320]
It is not officially listed among the most common adverse events in tirzepatide clinical trials
Managing expectations during month six By six months, clinical trial participants lost an average of 10 to 15 percent of their starting body weight, though individual results varied widely from five percent to over 20 percent depending on starting weight, dose achieved, and adherence to lifestyle modifications
Semaglutide (2.65 mg/mL): Suppresses appetite and cravings Regulates blood sugar and insulin levels Promotes sustained fat loss Extends feelings of fullness between meals L-Carnitine (100 mg/mL): Converts stored fat into usable energy Enhances endurance and stamina Supports muscle recovery and lean mass retention Boosts mitochondrial health and metabolic function Reduces fatigue and brain fog during weight loss
The most common issues are nausea, vomiting, diarrhea, constipation, and tiredness, especially as the dose goes up